ABC-12: Exploring the microbiome in patients (pts) with advanced biliary tract cancer (BTC) in a first-line study of durvalumab in combination with cisplatin/gemcitabine (cis/ gem)
Authors
McNamara, Mairead GTimmins, H.
Osborne, A.
Cox, R.
Wasan, H. S.
Corrie, P.
Gillmore, R.
Sivakumar, S.
Ma, Y. T.
Faluyi, O. O.
Arora, A.
Arif, S.
Canham, J.
Hurt, C.
Hubner, Richard A
Bridgewater, J. A.
Adams, R.
Valle, Juan W
Affiliation
University of Manchester/The Christie NHS Foundation Trust, Manchester,Issue Date
2023
Metadata
Show full item recordCitation
McNamara MG, Timmins H, Osborne A, Cox R, Wasan HS, Corrie P, et al. ABC-12: Exploring the microbiome in patients (pts) with advanced biliary tract cancer (BTC) in a first-line study of durvalumab in combination with cisplatin/gemcitabine (cis/ gem). Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772005635.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2023.41.16_suppl.TPS4183Additional Links
https://dx.doi.org/10.1200/JCO.2023.41.16_suppl.TPS4183Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/JCO.2023.41.16_suppl.TPS4183